February 2025 – Page 13 – Talk Bio

Actionable Insights Powered by AI

Boehringer Ingelheim’s Nerandomilast Achieves Second Phase III Success in Pulmonary Fibrosis Treatment

2 months ago talkbio0Tagged Boehringer, FIBRONEER-ILD, Force, Idiopathic Pulmonary Fibrosis, Ingelheim, nerandomilast, Phase 3 Clinical Trials, Progressive, Pulmonary Fibrosis, Respiratory physiology, Vital capacity

Nerandomilast, Boehringer Ingelheim, Phase III trial, FIBRONEER-ILD, progressive pulmonary fibrosis, idiopathic pulmonary fibrosis, lung function, forced vital capacity

Merck KGaA in Advanced Negotiations to Acquire SpringWorks Therapeutics

2 months ago talkbio0Tagged Acquisition, biopharmaceutical industry, cancer treatments, Does speak, Merck KGaA, Ogsiveo, SpringWorks

Merck KGaA, SpringWorks Therapeutics, acquisition talks, biopharmaceutical industry, rare diseases, cancer treatments, Ogsiveo

Eli Lilly Expands Pipeline with Strategic Deals in MASH and Cancer Therapies

2 months ago talkbio0Tagged AdvanCell, alpha therapies, Cancer Therapeutic Procedure, cardiometabolic diseases, cellular targeting, Eli, Eli Lilly, Interferes with, MASH, OliX, Radiopharmaceuticals, RNA

Eli Lilly, OliX Pharmaceuticals, AdvanCell, MASH, targeted alpha therapies, radiopharmaceuticals, RNA interference, cardiometabolic diseases, cancer treatment

Boehringer Ingelheim’s Nerandomilast Succeeds in Second Phase III Lung Fibrosis Trial, Paving Way for FDA Approval

2 months ago talkbio0Tagged Approved, Boehringer, FIBRONEER-ILD, fibrosing, Improvement, Ingelheim, Inhibitor, nerandomilast, PF-ILDs, Phase 3 Clinical Trials, phosphodiesterase 4B, Progressive, Respiratory physiology, United States Food and Drug Administration

Nerandomilast, Boehringer Ingelheim, Phase III trial, FIBRONEER-ILD, progressive fibrosing interstitial lung diseases (PF-ILDs), lung function improvement, FDA approval, phosphodiesterase 4B (PDE4B) inhibitor

Hims & Hers Super Bowl Ad Sparks Controversy Over Weight Loss Drug Marketing

2 months ago talkbio0Tagged Consumer Safety, Dosage Forms, Glucagon-Like Peptide 1, Hims & Hers, scrutiny, Super Bowl ad, Telemedicine, United States Food and Drug Administration, Weight-Loss Agents

Hims & Hers, Super Bowl ad, weight loss drugs, FDA scrutiny, compounded GLP-1 drugs, pharmaceutical advertising, telehealth, consumer safety

22 States Sue Trump Administration Over Drastic NIH Funding Cuts

2 months ago talkbio0Tagged Indirect, Medical Research activity, NIH Mouse, Research Projects, R-Series, Transplant Registry Unified Management Program, Universities

NIH funding, indirect costs, research grants, Trump administration, lawsuit, universities, medical research

Federal Judge Orders Trump Administration to Comply with Ruling Against Federal Funding Freeze

2 months ago talkbio0Tagged Administration occupational activities, Biomechanical compliance, federal, Judge, Lawyer (occupation), Transplant Registry Unified Management Program, Trump, Violation

federal funding freeze, court order violation, Judge John McConnell, Trump administration, state attorneys general, federal grants, compliance

J&J’s Swift $14.6B Acquisition of Intra-Cellular Therapies: A CEO-Driven Deal

2 months ago talkbio0Tagged Acquisition, Caplyta, Drug Industry, Duato, Intra-Cellular Therapies, Joaquin, Johnson and Johnson, M&A, Neuroscience discipline

Johnson & Johnson, Intra-Cellular Therapies, acquisition, neuroscience, CAPLYTA, Joaquin Duato, pharmaceutical industry, M&A

ViiV Healthcare’s Multifaceted Approach to Combating HIV in Black Communities

2 months ago talkbio0Tagged Black Populations, care activity, Community, community grants, HIV Prevention, Indication of (contextual qualifier), Risk, Social stigmata, ViiV Healthcare

ViiV Healthcare, HIV prevention, Black communities, Risk to Reasons, community grants, stigma reduction, education, access to care

AI-Driven Discovery Unveils Novel Antimicrobial Proteins Effective Against Bacterial and Fungal Infections in Mice

2 months ago talkbio0Tagged Artificial Intelligence, Bacterial Infections, Drug Discovery, in vivo studies, Microbicides, Mycoses, Peptides, protein compounds

Artificial intelligence, protein compounds, antimicrobial peptides, drug discovery, bacterial infections, fungal infections, in vivo studies